Cargando…

Impact of COVID-19 on patients with atopic dermatitis

Data on the tolerability and response to biologic therapies for type 2 immune disorders in the context of coronavirus disease 2019 (COVID-19) are currently lacking. Our survey aimed at assessing the adherence of patients to dupilumab therapy and the risk of the severe acute respiratory syndrome coro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grieco, Teresa, Chello, Camilla, Sernicola, Alvise, Muharremi, Rovena, Michelini, Simone, Paolino, Giovanni, Carnicelli, Giorgia, Pigatto, Paolo Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	COVID-19: Important updates and developments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285243/ https://www.ncbi.nlm.nih.gov/pubmed/34920828 http://dx.doi.org/10.1016/j.clindermatol.2021.07.008

Ejemplares similares

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis()()
por: Chello, Camilla, et al.
Publicado: (2021)

The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy
por: Paolino, Giovanni, et al.
Publicado: (2023)

Management of laser treatments during the coronavirus disease 2019 pandemic: The Italian experience
por: Bennardo, Luigi, et al.
Publicado: (2021)

Self-reported measure of subjective distress in response to COVID-19 pandemic in patients referred to our skin cancer unit during the first wave
por: Borsari, Stefania, et al.
Publicado: (2022)

The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy
por: Gualdi, Giulio, et al.
Publicado: (2021)

Dermatologic reactions to disinfectant use during the COVID-19 pandemic
por: Goh, Choon Fu, et al.
Publicado: (2021)

Addendum to: Eruption as a clinical manifestation of COVID-19: Photographs of a patient
por: Hoenig, Leonard J., et al.
Publicado: (2021)

Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
por: Lipsker, Dan
Publicado: (2020)

Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children
por: Brumfiel, Caitlin M., et al.
Publicado: (2021)

Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate
por: Lavery, Michael Joseph, et al.
Publicado: (2021)

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
por: Pi, Zixin, et al.
Publicado: (2020)

Changing gears: Medical gloves in the era of coronavirus disease 2019 pandemic
por: Anedda, Jasmine, et al.
Publicado: (2020)

Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases
por: Pawar, Manoj, et al.
Publicado: (2020)

Could injured skin be a reservoir for SARS-CoV-2 virus spread?
por: Elgarhy, Lamia Hamouda, et al.
Publicado: (2020)

A case for palliative dermatology: COVID-19–related dermatoses
por: Ho, Bernard, et al.
Publicado: (2020)

COVID toes or pernio?
por: Zaladonis, Angela, et al.
Publicado: (2020)

A dermatologic perspective on multisystem inflammatory syndrome in children
por: Naka, Fludiona, et al.
Publicado: (2021)

COVID-19 (SARS-CoV-2) infection presenting as acute urticaria
por: Farhan, Mariam, et al.
Publicado: (2021)

Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19
por: Galimberti, Fabrizio, et al.
Publicado: (2020)

Remdesivir: A giant step, or a tiptoe?
por: Dickinson, Gordon M.
Publicado: (2020)

Reply: Introducing special cutaneous “sign” tribute to health care workers managing new coronavirus disease (COVID-19)—new additions
por: Kannangara, Ajith P.
Publicado: (2021)

Impact of COVID-19 pandemic on the management of cutaneous lymphomas
por: Mateeva, Valeria, et al.
Publicado: (2021)

“Do-not-resuscitate (DNR)” status determines mortality in patients with COVID-19
por: Alhatem, Albert, et al.
Publicado: (2021)

In memoriam: Physicians who have died of COVID-19 in the United States
por: Hoenig, Leonard J.
Publicado: (2020)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Survey to evaluate the patient experience of virtual telephone consultations during the COVID-19 pandemic
por: Lavery, Michael Joseph, et al.
Publicado: (2021)

Impact of COVID-19 on medical practice: A nationwide survey of dermatologists and health care providers in Iraq
por: Shanshal, Mohammed, et al.
Publicado: (2021)

A dermatologic perspective on multisystem inflammatory syndrome in children
por: Naka, Fludiona, et al.
Publicado: (2021)

Clinicopathologic features between different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2021)

Dermatopathology resident training and education during the COVID-19 pandemic: Challenges faced and lessons learned
por: Mahmood, Muhammad N.
Publicado: (2021)

Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)

Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis
por: Capoferri, Gioele, et al.
Publicado: (2022)

A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2
por: Schroeder, Jan Walter, et al.
Publicado: (2022)

Clinicopathologic features among different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2022)

Cutaneous adverse effects of the available COVID-19 vaccines
por: Bogdanov, Georgi, et al.
Publicado: (2021)

COVID-19: The Italian experience
por: Musumeci, Maria Letizia, et al.
Publicado: (2021)

Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals
por: Ramirez-Quizon, Mae, et al.
Publicado: (2021)

COVID-19–related skin manifestations: Update on therapy
por: Atzori, Laura, et al.
Publicado: (2021)

COVID-19 and Dermatology in Iran
por: Mansouri, Parvin, et al.
Publicado: (2021)

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa
por: Iannone, Michela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ij9j1mhkuud5lec5vjmjcfpfr